Stock screenerAll disclosures →
EDGAR →
TFX
Conviction 49HealthcareScan · Thu, Jun 25, 2026TFX$127.83+1.04%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 489.02K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price127.83
Change+1.04%
Gap-0.41%
Rel volume0.77×
Avg volume541.93K
Avg $ vol69.64M
SMA 20128.56
SMA 50129.60
SMA 200120.16
Price vs 50-1.36%
Price vs 200+6.38%
MA stackmixed
50/200 cross—
Supertrenddown · 135.29
RSI (14)49
MACD hist-0.54
MACD crossbear · 9d
Stoch %K / %D44 / 34
ADX (14)16
+DI / −DI19 / 22
RSI divergenceBearish
MACD divergence—
ATR %+3.15%
ADR %2.83%
52w high138.81
52w low100.34
From 52w high-7.91%
Above 52w low+27.40%
New 52w highNo
SqueezeOff
Bollinger width9.72%
%B0.44
Donchian pos44.31%
Donchian high136.59
Donchian low120.86
AVWAP (52w high)130.67
vs AVWAP high-2.17%
AVWAP (52w low)119.02
vs AVWAP low+7.40%
OBV trendDown
Chaikin MF (20)-0.05
Today vs 20d0.77×
Avg vol (14d)489.02K
Avg vol (20d)541.93K
Avg $ vol (20d)69.64M
Market cap5.66B
RS 3m (vs SPY)+6.46%
RS 6m (vs SPY)-3.95%
RS line new highNo
Trend template4/8
Technical rank53.9
1 week+2.30%
1 month-3.08%
3 months+18.16%
6 months+2.68%
1 year+6.44%
YTD+4.44%
P/E-6.25
P/B1.83
P/S2.84
P/FCF3913.60
EPS-20.25
Div yield1.06%
ROE-29.36%
ROA-13.35%
Debt/Eq0.85
Current2.55
EV/EBITDA26.89
Gross margin56.24%
Net margin-45.45%
Rev growth17.25%
EPS growth-1399.81%
Price target146.00
Target upside14.21%
Analyst ratingBuy
Institutional120.46%
Ent. value7.96B
Revenue548.26M
Net income-8.15M
Gross profit307.43M
Free cash flow1.45M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out44.27M
Employees15.5K
ListedThu, Jun 1, 1972
Free float43.4M
Float %98.1%
Short interest2.38M
Days to cover3.3d
Short volume68.2%
Squeeze score46 / 100
Next earningsThu, Jul 30, 2026 (35d)
EPS forecast$1.28 · 11 est
Last EPS vs est$1.39 vs $1.21
Last surprise+14.9% beat
Setup gradeC
Conviction49 / 100
Pattern quality—
Tech rank53.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance136.19
Support119.69
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TFX · 3 recent
Insider activity
SEC Form 4 transactions in TFX · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Weidman Jason R. President and CEO · Common Stock · 2026-06-08 | Grant | 53.98K | $0 | 2026-06-08 | 2026-06-09 |
RANDLE STUART A Director · Common Stock · 2026-06-08 | Grant | 4.66K | $0 | 2026-06-08 | 2026-06-09 |
Weidman Jason R. President and CEO · Stock Option / (Right to Buy) · 2026-06-08 | Grant | 26.07K | $0 | 2026-06-08 | 2026-06-09 |
RANDLE STUART A Director · Stock Option / (Right to Buy) · 2026-06-08 | Grant | 2.19K | $0 | 2026-06-08 | 2026-06-09 |
RANDLE STUART A Director · Common Stock · 2026-06-08 | Grant | 995 | $0 | 2026-06-08 | 2026-06-09 |
RANDLE STUART A Director · Common Stock · 2026-06-07 | Tax | 4.05K | $526K | 2026-06-07 | 2026-06-09 |
TOKICH MICHAEL J Director · Stock Option / (Right to Buy) · 2026-05-15 | Grant | 4.79K | $0 | 2026-05-15 | 2026-05-19 |
Duncan Candace H Director · Stock Option / (Right to Buy) · 2026-05-15 | Grant | 2.4K | $0 | 2026-05-15 | 2026-05-19 |
Krakauer Andrew A Director · Stock Option / (Right to Buy) · 2026-05-15 | Grant | 2.4K | $0 | 2026-05-15 | 2026-05-19 |
Duncan Candace H Director · Common Stock · 2026-05-15 | Grant | 1.09K | $0 | 2026-05-15 | 2026-05-19 |
SEC filings
EDGAR filings in TFX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.